Las Vegas-based tech startup Regara can cut the time-consuming FDA approval process in half, which, for a drug like Ozempic, would be worth more than $100 billion in sales. Original article: https://www.reviewjournal.com/business/vegas-business/innovation/angelnv-winner-regara-can-cut-lengthy-fda-approval-process-in-half-3825466/
